Featured Research

from universities, journals, and other organizations

Sun-damaged Skin Responds Well To Laser Treatment

Date:
October 24, 2008
Source:
University of Michigan Health System
Summary:
Researchers have found scientific evidence that the appearance of sun-damaged skin may be improved by treatment with a topical product that increases the skin's sensitivity to light, followed by laser therapy.

Researchers at the University of Michigan Health System Department of Dermatology have found scientific evidence that the appearance of sun-damaged skin may be improved by treatment with a topical product that increases the skin's sensitivity to light, followed by laser therapy.

In the new study, participants whose skin was sun-damaged – or photodamaged – were treated with a topical photosensitizer called 5-aminolevulinic acid (5-ALA) and then with a pulsed dye laser. This type of treatment, known as photodynamic therapy, increased collagen levels in the skin and also produced other skin changes that are known to improve its appearance.

The results also suggest that skin with the worst sun damage may respond particularly well to this treatment.

"This is new scientific evidence that photodynamic therapy may in fact be a useful tool to improve the appearance of the skin. This type of therapy has been performed in clinical practice for the past few years, but we've never had detailed molecular evidence for why it may work," says lead author Jeffrey S. Orringer, M.D., associate professor of dermatology at the U-M Health System and director of U-M's Cosmetic Dermatology and Laser Center. The study appears in the October issue of the Archives of Dermatology.

The study looked at 24 adults, ages 54 to 83, all of whom had significant photodamage on the forearm skin. They received a three-hour application of 5-ALA followed by pulsed dye laser therapy. Researchers examined biopsies taken before and at several times after the treatments, and they recorded the molecular changes in the participants' skin at various stages.

Among many other molecular changes, levels of the proteins procollagen I and procollagen III increased after treatment. For instance, one month after treatment, levels of procollagen I peaked with an increase of 2.65 times the pre-treatment levels. Procollagen III peaked one month after treatment with an increase of 3.32 times the pre-treatment levels. Other protein levels molecular markers also increased.

The study represents the latest example of U-M's human appearance research program's unraveling of the mechanisms by which popular treatments improve the appearance of the skin, Orringer notes.

The group has studied the treatment of sun-damaged skin with estrogen, the science behind wrinkle treatments, the effects of smoking on aging skin, and more.

Photodynamic therapy has been used as a treatment for precancerous lesions called actinic keratoses and for some types of skin cancer, but little scientific research has been conducted about its use in appearance-oriented dermatology.

Future studies are needed to gauge whether the improvements shown in the forearm skin in this study can be replicated on facial skin.

Authors: In addition to Orringer, authors of the paper – all from the U-M Department of Dermatology – were senior author John J. Voorhees, M.D., FRCP, Duncan and Ella Poth Distinguished Professor and chairman of the Department of Dermatology; Craig Hammerberg, Ph.D., laboratory manager; Ted Hamilton, M.S., senior research associate; Timothy M. Johnson, M.D., professor and director of the Cutaneous Surgery and Oncology Unit and the Melanoma Clinic; Sewon Kang, M.D., formerly a professor of dermatology at U-M; Dana L. Sachs, M.D., associate professor; and Gary Fisher, Ph.D., Harry Helfman Professor of Molecular Dermatology.

Funding: The study was funded by the Human Appearance Research Program (HARP) of the U-M Department of Dermatology.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Molecular Effects of Photodynamic Therapy for Photoaging. Archives of Dermatology, Vol. 144, No. 10, October 2008

Cite This Page:

University of Michigan Health System. "Sun-damaged Skin Responds Well To Laser Treatment." ScienceDaily. ScienceDaily, 24 October 2008. <www.sciencedaily.com/releases/2008/10/081020171335.htm>.
University of Michigan Health System. (2008, October 24). Sun-damaged Skin Responds Well To Laser Treatment. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/10/081020171335.htm
University of Michigan Health System. "Sun-damaged Skin Responds Well To Laser Treatment." ScienceDaily. www.sciencedaily.com/releases/2008/10/081020171335.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins